Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 2653 Records) |
| Query Trace: Pharmacogenomics[original query] |
|---|
| A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity. European journal of pain (London, England) 2024 12 29 (1): e4764. Francesca Minnai, Morena Shkodra, Sara Noci, Martina Esposito, Cinzia Brunelli, Alessandra Pigni, Ernesto Zecca, Frank Skorpen, Pål Klepstad, Stein Kaasa, Oscar Corli, Maria C Pallotti, Marco C Maltoni, Augusto T Caraceni, Francesca Colom |
| Do CYP2D6 genotypes affect oxycodone dose, pharmacokinetics, pain, and adverse effects in cancer? Pharmacogenomics 2024 12 1-8. Aaron K Wong, Sara Vogrin, Pal Klepstad, Justin Rubio, Brian Le, Jennifer Philip, Andrew A Somog |
| Clinical predictors of 3-month isoniazid rifapentine (3HP)-related adverse drug reactions (ADR) during tuberculosis preventive therapy (PAnDoRA-3HP study): an observational study protocol. BMJ open 2024 12 14 (12): e088389. Christine Sekaggya-Wiltshire, Irene Mbabazi, Ruth Mirembe Nabisere, Lucy Alinaitwe, Brian Otaalo, Florence Aber, Juliet Nampala, Rogers Owori, Josephine Bayigga, Jonathan Mayito, Grace Banturaki, Eva Agnes Odongpiny Laker, Barbara Castelnuovo, Moorine Penninah Sekadde, Jotam Pasipanodya, Kelly E Dooley, Turyahabwe Stavia, Stella Zawedde-Muyan |
| The Association of PLA2G7 Gene Polymorphisms with Serum Lp-PLA2 Activity and Lipid Profile in Han Chinese Patients with Coronary Heart Disease. Pharmacogenomics and personalized medicine 2024 12 17 563-572. Yanhai Wang, Yupeng Shi, Zhongwei Wu, Jiangfeng Gao, Jing Wang, Lei Li, Yugang Wan, MuGu Lang A, Jianwen Zhang, Hongbo Wang, Yu H |
| PEAR1, PON1, CYP2C19, CYP1A2 and F2R Polymorphisms are Associated with MACE in Clopidogrel-Treated Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Pharmacogenomics and personalized medicine 2024 12 17 611-621. Pengqiang Du, Xingang Li, Dandan Li, Yongcheng Ma, Ming Ni, Yafei Li, Wenbo Li, Aifeng Wang, Xiaowei |
| Associations Between the Polymorphisms in the Coding Sequence of SLCO1B1 and Blood Lipid Levels Before and After Treatment by Atorvastatin in the Chinese Han Adults with Dyslipidemia. Pharmacogenomics and personalized medicine 2024 12 17 551-561. Chao Chen, Yan Tian, Fengshun Jia, Mingkun Feng, Guoqiang Zhang, Qian Li, Yanwei Zhang, Ningling Sun, Songnian Hu, Zheng |
| Updated analysis of the pharmacogenomics of pediatric bronchodilator response. Pharmacogenetics and genomics 2024 12 . Jennifer Brailsford, Guillaume Labilloy, Nolan Menze, Morgan Henson, Jennifer Fis |
| Pharmacogenomic Study of Selected Genes Affecting Amlodipine Blood Pressure Response in Patients with Hypertension. Pharmacogenomics and personalized medicine 2024 11 17 473-486. Asif Jan, Abdullah R Alanzi, Ramzi A Mothana, Jun-Ya Kaimori, Syed Shaukat Ali, Tahir Muhammad, Muhammad Saeed, Rani Akbar, Mehtab Kh |
| Association between the CYP2B6 polymorphisms and nonnucleoside reverse transcriptase inhibitors drug-induced liver injury: a systematic review and meta-analysis. Scientific reports 2024 11 14 (1): 29511. Noppadol Chanhom, Janjira Sonjan, Jarupat Inchai, Wanvisa Udomsinprasert, Usa Chaikledkaew, Supharat Suvichapanich, Surakameth Mahasirimongkol, Jiraphun Jittiko |
| Plasma concentrations of venetoclax and Pharmacogenetics correlated with drug efficacy in treatment naive leukemia patients: a retrospective study. The pharmacogenomics journal 2024 11 24 (6): 37. Yue Li, Qing Wan, Jiaqi Wan, Xiong Xiao, Jinfang Hu, Xintong Yang, Fancong Kong, Jieyu Wang, Baoquan Song, Zhentao Li, Fei Li, Simei Ren, Hongwei Pe |
| Genetic association analysis and frequency of NUDT15*3 with thiopurine-induced myelosuppression in patients with inflammatory bowel disease in a large Dutch cohort. The pharmacogenomics journal 2024 11 24 (6): 39. Maarten J Deenen, Anouk J van Noordenburg, Joëlle Bouwens-Bijsterveld, Maarten A van Dijk, Janneke M Stapelbroek, Luc J J Derijks, Lennard P L Gilissen, Birgit A L M Deim |
| Effect of UGT1A6 and UGT2B7 polymorphisms on the valproic acid serum concentration and drug-induced liver injury. Pharmacogenomics 2024 11 1-12. Mengchen Yu, Yan Zhao, Fan Zhou, Weiliang Li, Jing Liu, Linlin Zhao, Zhirui Song, Ling Tong, Ying Zhang, Yajuan Wang, Shenglan Shang, Airong |
| Impact of genetic variants on fentanyl metabolism in major breast surgery patients: a candidate gene association study. Pharmacogenomics 2024 11 1-9. Shathish Kumar, Kesavan Ramasamy, Harivenkatesh Natarajan, Shravan Venkatraman, Vishnu Eriyat, Pankaj Kund |
| PPARA variant rs1800234 had a dose dependent pharmacogenetics impact on the therapeutic response to chiglitazar. Pharmacogenomics 2024 11 1-6. Zhaoxu Geng, Yuanting Zheng, Qian Li, Desi Pan, Xianping Lu, Fei Chen, Ying Zhang, Keying Li, Kaixin Zhou, Leming Shi, You Wa |
| Allele frequencies and genotype distribution of three metformin transporter polymorphisms in Mexican population and their application in pharmacogenomics of type 2 diabetes. Frontiers in pharmacology 2024 11 15 1466394. Oscar I Chávez-Arreola, Brissia Lazalde, Marisol López-López, Alberto Ortega-Vázquez, Quitzia L Torres-Salaz |
| Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic review. Parkinsonism & related disorders 2024 11 107206. Henry Mauricio Chaparro-Solano, Maria Rivera Paz, Saar Anis, Jennifer K Hockings, Avery Kundrick, Camila C Piccinin, Ekhlas Assaedi, Leila Saadatpour, Ignacio F Ma |
| Providers' use of pharmacogenetic testing to inform opioid prescribing among veterans. Pharmacogenomics 2024 10 1-7. Rachele K Lipsky, Catherine Chanfreau-Coffinier, Deepak Voora, Jodie Trafton, Charlotte Williams, Susana B Martins, Sumitra Muralidhar, David W Osl |
| Effects of genetic and clinical factors on thiopurine drugs pharmacokinetics in Tunisian patients. Pharmacogenomics 2024 10 1-10. Zohra Chadli, Ibtissem Hannachi, Manel Ben Belgacem, Arwa Guediche, Haifa Ben Romdhane, Emna Kerkeni, Lamia Hamdi, Ahlem Slama, Amel Chaabane, Nadia Ben Fredj, Naceur A Boughattas, Leila Safer, Karim Aou |
| Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients. The pharmacogenomics journal 2024 10 24 (6): 32. Samuel Huxley, James Moriarty, Mark A Hlatky, Ryan Lennon, Kent Bailey, Malcolm Bell, Nancy Geller, Amir Lerman, Verghese Mathew, Yves Rosenberg, Michael Farkouh, Charanjit Rihal, Bijan Borah, Naveen L Perei |
| Effects and interaction of single nucleotide polymorphisms at the pharmacokinetic/pharmacodynamic site: insights from the Rotterdam study into metformin clinical response and dose titration. The pharmacogenomics journal 2024 10 24 (6): 31. Soroush Mohammadi Jouabadi, Payam Peymani, Mitra Nekouei Shahraki, Jeroen G J van Rooij, Linda Broer, Anton J M Roks, Bruno H Stricker, Fariba Ahmadiz |
| Real-world evaluation of CYP2C19 guided antiplatelet therapy in patients undergoing intracranial aneurysm repair. Pharmacogenomics 2024 10 1-11. Layna P Fox, Kayla R Tunehag, Anh Nguyen, Samuel Reed, Darshan Shastri, Nathan Quig, George A Stouffer, Sten Solander, Craig R L |
| Genetic profiling of NUDT15 in the Slovenian population. Pharmacogenomics 2024 10 1-11. Alenka Šmid, Dunja Urban?i?, Jaka Vrevc Žlajpah, Natalia Stollarova, Tomaž Prelog, Marko Kav?i?, Janez Jazbec, Irena Mlinari?-Raš?an, Nataša Karas Kuželi? |
| Predicting laboratory aspirin resistance in Chinese stroke patients using machine learning models by GP1BA polymorphism. Pharmacogenomics 2024 10 1-12. Jun Liu, Linkun Pan, Sheng Wang, Yueran Li, Yilai Wu, Jiajie Luan, Kui Ya |
| Pharmacogenetic DPYD allele variant frequencies: A comprehensive analysis across an ancestrally diverse Iranian population. Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences 2024 10 . Negar Sarhangi, Fatemeh Rouhollah, Negar Niknam, Farshad Sharifi, Shekoufeh Nikfar, Bagher Larijani, George P Patrinos, Mandana Hasanz |
| Impact of FCGR2A rs1801274 and IL-6R rs2228145 polymorphisms on tocilizumab response in the Iranian population with severe COVID-19. BMC infectious diseases 2024 10 24 (1): 1168. Nastaran Injinari, Samira Asadollahi, Fateme Sefid, Maedeh Arshadi, Saeedeh Sadat Hosseini, Hamed Ghoshouni, Fatemeh Soltani, Nasim Namiranian, Mohammad Hasan Sheikhha, Fatemeh Aghaeimeybo |
| Effects of immunorelated gene polymorphisms on trastuzumab targeting breast cancer cell in vitro. Pharmacogenomics 2024 10 1-8. Linyu Yu, Congmin Zhang, Liangyu Liu, Xiaoping Ch |
| Shared chemoresistance genes in ESCC and cervical Cancer: Insights from pharmacogenomics and Mendelian randomization. International immunopharmacology 2025 1 147 113933. Ziyu Liu, Jie Liu, Yanhao Wu, Zongjiang Zhou, Diabate Ousmane, Zahra Zeinalzadeh, Junpu Wa |
| Evaluation of machine learning algorithms and computational structural validation of CYP2D6 in predicting the therapeutic response to tamoxifen in breast cancer. European review for medical and pharmacological sciences 2025 1 28 (24): 4712-4722. K Sridharan, K Sekaran, C George Priya Do |
| Pharmacogenomics predictors of aromatic antiepileptic drugs-induced SCARs in the Iraqi patients. Heliyon 2025 1 11 (1): e41108. Ali Fadhel Ahmed, Dzul Azri Mohamed Noor, Majeed Arsheed Sabbah, Nur Fadhlina Musa, Nur Aizati Athirah Da |
| CYP2C19 and CES1 gene variants affecting clopidogrel metabolism in a South Asian population from Sri Lanka. Pharmacogenomics 2025 1 1-4. Priyanga Ranasinghe, Pulasthi B Gunarathna, Hajanthy Jeyapragasam, Nirmala Sirisena, D P Bhagya Hendalage, Vajira H W Dissanaya |
- Page last reviewed:Feb 1, 2024
- Content source: